Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer
{{output}}
Objective: This study aimed to evaluate the maximum bone scan index in the jaw (BSIJmax) before the development of clinical medication-related osteonecrosis of the jaw (MRONJ) in patients with prostate cancer. ... ...
